SUMMARY One hundred consecutive cases of valve replacement for aortic regurgitation performed between 1967-1971 were analyzed to identify and quantitate factors related to a favorable result. Of 83 perioperative survivors, 78% (n = 65) became asymptomatic and 58% (n = 48) were alive 5-9 years postoperatively. The cause of aortic regurgitation affected both the speed of progression of symptoms and the postoperative result.
SUMMARY One hundred consecutive cases of valve replacement for aortic regurgitation performed between 1967-1971 were analyzed to identify and quantitate factors related to a favorable result. Of 83 perioperative survivors, 78% (n = 65) became asymptomatic and 58% (n = 48) were alive 5-9 years postoperatively. The cause of aortic regurgitation affected both the speed of progression of symptoms and the postoperative result.
Death due to myocardial failure may be prevented by optimal timing of operation. Accordingly, we identified variables that discriminated between patients who had an excellent postoperative result and those who died of myocardial failure. The most important discriminators were the severity (p = 0.03) and duration (p = 0.04) of dyspnea, the extent of therapy for heart failure (p = 0.001), physical findings of left ventricular failure (p = 0.002), the cardiothoracic ratio (p = 0.007), the resting pulmonary capillary wedge pressure (p = 0.01), and a cardiac index < 2.2 I/min/m' (p = 0.03).
The data suggest that evidence of left ventricular failure, even of mild degree, is an indication for operation in patients with severe aortic regurgitation.
THE MOST DIFFICULT DECISION in the management of patients with severe aortic regurgitation is determining the optimal time for valve replacement. Patients with advanced or progressive left ventricular failure or angina require operation. Patients with few or no symptoms despite severe aortic regurgitation, however, present a particular problem.' 3 When should one advise taking the surgical risk and commit the patient to the uncertainties of a prosthetic or tissue substitute valve? Or, at what point has one waited too long, increased the surgical mortality and jeopardized the postoperative result?
Guidelines to determine the timing of aortic valve replacement have been few and sometimes contradictory.4"10 Among patients with aortic regurgitation, Hegglin et al." report a 50% mortality 5 years after the developinent of angina and 2 years after the development of congestive failure. In young patients with aortic regurgitation, Spagnuolo et al.12 defined a high-risk group that had a wide pulse pressure, an electrocardiographic pattern of left ventricular "strain" and moderate cardiac enlargement. Eightyseven percent of these patients had angina, congestive failure, or died within 6 years, in contrast to an 8% incidence in a group without these features. Braun and his colleagues,'3 reporting their experience with valve replacement for either aortic stenosis or regurgitation, have shown a close correlation between the preoperative heart size and the postoperative survival curve. When the cardiothoracic ratio (CTR) was less than 0.56, the 5-year survival was 84%. In contrast, if the CTR was greater than 0.61, the 5-year survival was reduced to 46%. In a series of patients with pure aortic regurgitation, Smith et al. 5 reported that an unfavorable postoperative result was more frequent only when the CTR was greater than 0.65. In contrast, Hirshfeld et al. 4 found that preoperative symptoms, heart size and the cardiac index (CI) had no significant influence on survival. The extent of left ventricular hypertrophy in the ECG and, particularly, elevation of the left ventricular end-diastolic pressure (LVEDP), however, profoundly reduced the postoperative survival rate. When the LVEDP was less than 10 mm Hg, the 6-year survival was 74%, while in patients with an LVEDP greater than 20 mm Hg, the 6-year survival was only 30%. The speed of progression of symptoms is also important in the management of aortic regurgitation and has been shown by Rotman et al. '4 to be related to the etiology. Rapaport2 and Morganroth et al. 15 have stressed the importance of distinguishing acute from chronic aortic regurgitation in the proper timing of operation.
The purpose of the present study was to define the determinants of a favorable operative and postoperative course. One hundred consecutive cases of valve replacement for pure aortic regurgitation operated on between 1967-1971 were reviewed and subsequently followed 5-9 years. Clinical and laboratory data were analyzed to identify variables that significantly affected the postoperative result. Quantitation of these data permitted us to identify limits beyond which the postoperative result was likely to be impaired. Methods The hospital records of all patients who underwent aortic valve replacement between 1967-1971 were reviewed. We selected this interval to permit a minimum follow-up period of 5 years, accepting the higher operative mortality of that time. From these 480 cases, we identified 100 consecutive patients who had aortic regurgitation as the only valvular lesion. We analyzed the data to identify the clinical and laboratory variables that predicted the postoperative result. Special attention was given to variables that discriminated between patients achieving an excellent result and those dying from myocardial failure. The causes of death and the complications during the follow-up period were also analyzed. All calculations were performed using a Xerox Sigma 3 computer, and statistical analyses were performed using one-way analysis of variance to compare multiple groups. The Fisher exact test was used for analysis of discrete variables.
Results

Patient Population
The age of patients in this study ranged from 15-78 years, with a mean of 49 ± 1.4 (SEM) years; 75% of the patients were male. The mean NYHA class was 3.2 ± 0.1 and the mean therapeutic index 2.3 ± 0.1, indicating that the population as a whole had advanced symptoms despite substantial therapy. The mean breakpoint was 11 ± 1.7 months. Fifty-two patients underwent cardiac catheterization, but did not differ significantly from the total series with respect to any of the above parameters.
The causes of aortic regurgitation in this series are listed in table 1. It is apparent that the cause was closely related to the breakpoint, so that specific causes could be assigned to acute, subacute, or chronic categories. Since the mean NYHA class at the time of operation did not differ significantly among these three categories (3.1 ± 0.2, 3.0 i 0.4, and 3.6 ± 0.2, respectively), the breakpoint in part reflects the speed of progression of symptoms. Infective endocarditis was present in 26% of the patients and, even when bacteriologically cured, tended to behave as a rapidly progressing process and required operation an average of 3 months after the development of significant symptoms. The predominant symptoms in the series included dyspnea in 85%, angina in 40%, and syncope or presyncope in 11% of the patients. The relationship of the NYHA class to the result of operation is shown in table 2. The three deaths among class I patients were due to surgical complications in the postoperative Table 7 is a list of selected variables that did not significantly discriminate between these two groups of patients. Increased age, diastolic blood pressure, an electrocardiographic pattern of left ventricular "strain," and the pump time were not associated with an increase in the incidence of myocardial death, but separate analysis indicated that they were associated with a higher operative mortality. The NYHA class as a discriminator between excellent results and myocardial deaths was of borderline statistical significance (p = 0.06). In contrast, the extent of therapy for congestive failure, reflected by the therapeutic index, was a highly significant discriminator (p = 0.001). Although the severity and duration of dyspnea discriminated between the excellent results and myocardial deaths, the severity and duration of angina and syncope did not.
Because the conclusions of previous studies conflict,4 57. 8 reduced from 81% to 48% when the CTR was 0.64 or above (p = 0.004), and from 79% to 59% when the CTR was above 0.60 (p = 0.05). Tables 9 and 10 results of valve replacement for aortic regurgitation, however, have not included a consideration of the cause. The present study confirms and extends the conclusion of Rotman et al.14 by showing that the speed of progression of symptoms, reflected in our study by the breakpoint, is closely related to the cause of aortic regurgitation (table 1) . In addition, our data show that the operative risk and the postoperative course are also significantly influenced by the cause of the regurgitation.
Infective endocarditis presented two specific problems. First, in the presence of active infection, valve replacement may be unduly delayed in an attempt to achieve a bacteriologic cure. Recent reports have emphasized this important clinical problem.23 25 12 patients died of myocardial failure, and it is in this group that optimal timing of operation could have favorably influenced the result. Four of these deaths occurred during the surgical admission and eight during the follow-up period. Three of these eight had evidence of congestive failure in the perioperative period and seven of the eight had poor functional results from the time of hospital discharge. Therefore, all deaths due to myocardial failure were segregated and considered as a single group, although the total number of patients in this category was relatively small. We have excluded from this group the late deaths that were sudden (20%) because they occurred in the absence of congestive failure. They may have been due to dysrhythmia related to abnormality of myocardial function, but on separate analysis they were not associated with pre-or postoperative rhythm disturbance or with any other factor analyzed in this study.
The purpose of this study was to identify variables Although the PCWP was an important determinant of the postoperative result, the LVEDP was not (table  7) . This is in contrast to previous data in which the effect of the LVEDP on total patient mortality was analyzed. 4 The explanation for the lack of predictive value of the LVEDP in our study is uncertain. However, alterations in left ventricular chamber stiffness recently documented in the volumeoverloaded ventricle26 could lead to a discrepancy between the levels of the LVEDP and the mean PCWP in the setting of aortic regurgitation.
The timing of operation in the asymptomatic or minimally symptomatic patient with severe aortic regurgitation will continue to present a difficult management problem. In these patients, cardiac catheterization may be needed to confirm the presence of severe regurgitation and to clarify the relationship of hemodynamic abnormality to symptoms or to increasing heart size. Catheterization may also be required to answer specific questions, such as the presence of coronary artery disease, aneurysm, or dissection of the ascending aorta. Invasive studies are less desirable for the repeated assessment of left ventricular function. Noninvasive methods, including echocardiography27' 28 and radionuclide ventriculography29 may permit the earlier identification of left ventricular dysfunction as a guide to the optimal timing of operation.
Quantitation of the factors that discriminated between patients who had an excellent result and those who died of myocardial failure permitted the definition of cutoff points, beyond which a patient begins to enter a higher risk category and the postoperative result is likely to be jeopardized. Guidelines to these are as follows: 1) dyspnea on less effort than walking one block or climbing one flight of stairs at a normal speed as a symptom of left ventricular failure;
2) the need for therapy in excess of a no-added salt diet, digoxin, and a diuretic dose equivalent to 500 mgm chlorothiazide daily (i.e., therapeutic index > 3);
3) the presence of rales or an S3 gallop as evidence of left ventricular failure; 4) a CTR > 0.64 or progressive increase in heart size above a CTR of 0.60; 5) a resting PCWP > 12 mm Hg; 6) a resting CI < 2.2 I/min/m2.
It is inappropriate to delay operation until a patient is clearly in a high-risk category. However, one would expect the operative result to be more favorable in the patient who is approaching or who has just reached one of these limits than in the patient whose disease has been allowed to progress further. Although additional evaluation of these predictors by prospective study is desirable, the results of this study suggest that when a patient begins to fulfill any one of the above guidelines, operation should be seriously considered.
